Harmon Cyrus

DirectorOlema Pharmaceuticals, Inc. (OLMA) · full profile →Form 4 · filed Sep 18, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$205K
Net Open-Market Flow
-$205K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 18, 2025Sell(S)10K$8.33$83K744K
Sep 18, 2025Sell(S)3K$8.32$26K117K
Sep 16, 2025Sell(S)10K$8.04$80K754K
Sep 16, 2025Sell(S)2K$8.08$15K120K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001831410-25-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly: